Bristol-Myers Squibb
Headquarters country
United States
Registry sponsor category
Industry
- Company name
- Bristol-Myers Squibb
- Organisation type
- Industry
- Registered legal name
- BRISTOL MYERS SQUIBB CO
- US industry code (SIC)
- Pharmaceutical preparations
- Registry sponsor category
- Industry
- Website
- https://www.bms.com/
- Bristol Myers Squibb Company (BMS)
- Bristol-Myers Squibb
- SEC filer number (CIK)
- 0000014272
- Wikidata ID
- Q266423
Related records
Trials (2,870)
- 12- Week Open Label Treatment of Refractory Bipolar Depression
- 18-week add-on to Metformin Comparison of Saxagliptin and Sitagliptin in Adult Patients With Type 2 Diabetes (T2D)
- 18F-PD-L1 PET/CT in Nivolumab Treated Patients With NSCLC
- 2015-10: Expanded Natural Killer Cells and Elotuzumab for High-Risk Myeloma Post- Autologous Stem Cell Transplant (ASCT)
- 52-week add-on to Metformin Comparison of Saxagliptin and Sulphonylurea, With a 52-week Extension Period
- 6 FEC 100 Vs 4 FEC 100 Followed by 4 Taxol in N+ Breast Cancer
- A "Physician & Patient-powered" Cohort Registry (MY MYELOMA)
- A 5-year Observational Follow-up Study to Describe Treatment Patterns in Real World of HCV Patients in China.
- A Belatacept Compassionate Use Study for Patients With a Kidney Transplant
- A Bioequivalence Study of Daclatasvir Tablets and Bioavailability Studies of Daclatasvir and Asunaprevir
- A Bioequivalence Study of the Fixed Dose Combinations of Saxagliptin/Metformin XR Relative to Co-Administration
- A Biomarker Study in Advanced Mucosal or Acral Lentiginous Melanoma Receiving Nivolumab in Combination With Ipilimumab
- A Blinded Study to Evaluate Effect on Atrial Fibrillation Burden in Patients With Paroxysmal Atrial Fibrillation
- A Brain Metastases Research Platform to Tackle the Challenge of CNS Metastases in Solid Tumours
- A Clinical Study Evaluating Nivolumab-containing Treatments in Patients With Advanced Non-small Cell Lung Cancer After Failing Previous PD-1/(L)1 Therapy and Chemotherapy
- A Clinical Trial of Entinostat in Combination With Nivolumab for Patients With Previously Treated Unresectable or Metastatic Cholangiocarcinoma and Pancreatic Adenocarcinoma
- A Clinical Trial Testing the Safety of Pumitamig (an Investigational Drug) and How Well it Works When Combined With Chemotherapy for People Who Have Not Been Treated Yet for Pancreatic Cancer
- A Clinical Trial Testing the Safety of the Investigational Drug Pumitamig (BNT327) and How Well it Works in Patients With Recurrent Glioblastoma
- A Combination of Ipilimumab and Fotemustine for Treat Unresectable Locally Advanced or Metastatic Melanoma
- A Companion Study for Patients Enrolled in Prior/Parent Ipilimumab Studies